[{"id":"fab296e5-5776-4c85-9ae1-37929f5d2dea","acronym":"","url":"https://clinicaltrials.gov/study/NCT05686226","created_at":"2023-01-17T14:59:13.286Z","updated_at":"2024-07-02T16:35:33.810Z","phase":"Phase 2","brief_title":"E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers","source_id_and_acronym":"NCT05686226","lead_sponsor":"Christian Hinrichs","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • E7 TCR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 03/07/2023","start_date":" 03/07/2023","primary_txt":" Primary completion: 01/01/2025","primary_completion_date":" 01/01/2025","study_txt":" Completion: 01/01/2025","study_completion_date":" 01/01/2025","last_update_posted":"2023-10-12"},{"id":"cd9c68a8-062c-418a-8a7a-3f467abc3209","acronym":"","url":"https://clinicaltrials.gov/study/NCT05639972","created_at":"2022-12-07T16:57:48.136Z","updated_at":"2024-07-02T16:35:33.860Z","phase":"Phase 1/2","brief_title":"E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers","source_id_and_acronym":"NCT05639972","lead_sponsor":"Christian Hinrichs","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • Proleukin (aldesleukin) • E7 TCR cells • E7 TCR-T"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 06/12/2024","start_date":" 06/12/2024","primary_txt":" Primary completion: 10/01/2026","primary_completion_date":" 10/01/2026","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2023-10-11"}]